reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT05958017
- Status
- Recruiting
Conditions
- People Living With HIV
- Stimulant Use Disorder
- reSET
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- reSET — BEHAVIORALParticipants in this group will use a mobile application that delivers treatment for substance use disorder. 31 required and 30 optional modules. Among many topics covered in the modules, some are substance use management, communication, emotion management, relationship skills, HIV/Sexually Transmitted Infections and triggers for risky sex. In the reSET app you will get the chance to earn rewards for two activities: (1) completing a module and (2) providing a negative urine drug screen in exchange for a motivational or monetary prize. You will have 12 weeks to complete as many modules as you like, about 4 modules per week. Each module takes approximately 10-15 min. Every 3-4 days you will meet with the same study team member to provide a urine drug screen from a place comfortable for you (e.g. home) which will be observed and read via Zoom.
- Standard of care — OTHERParticipants in this group will receive assistance connecting to an in person community-based outpatient treatment program.
Study Details
The purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Key Dates
- Start date
- Mar 4, 2025
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 500 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: reSET GroupParticipants in this group will use the reSET mobile app for 12 weeks.
- Other: Standard of Care GroupParticipants in this group will receive standard of care treatment for 12 weeks.
Primary Outcome Measure
Change in days of stimulant use as measured by Timeline FollowBack [ Time Frame: 3, 9 and 15 months. ]
Central Contacts
- Jose Szapocznik, PhD(305) 6105723
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Jose Szapocznik, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By research site
Related Studies
- Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted TreatmentPHASE2 · Recruiting · Washington State University · Spokane, Washington
- Orexin Receptor Antagonism and Sleep in Stimulant Use DisorderPHASE2 · Recruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug UseRecruiting · Elana Rosenthal · Washington D.C., District of Columbia
- Optimizing Transcranial Magnetic Stimulation for Stimulant Use DisorderPHASE1 · Recruiting · University of Minnesota · Minneapolis, Minnesota